Logo image of GTH

GENETRON HOLDINGS LTD-ADR (GTH) Stock Fundamental Analysis

NASDAQ:GTH - Nasdaq - US37186H2094 - ADR - Currency: USD

4.025  +0.01 (+0.12%)

After market: 4.0201 0 (-0.12%)

Fundamental Rating

2

Overall GTH gets a fundamental rating of 2 out of 10. We evaluated GTH against 571 industry peers in the Biotechnology industry. Both the profitability and financial health of GTH have multiple concerns. GTH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GTH has reported negative net income.
GTH had a negative operating cash flow in the past year.
In the past 5 years GTH always reported negative net income.
GTH had a negative operating cash flow in each of the past 5 years.
GTH Yearly Net Income VS EBIT VS OCF VS FCFGTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 -1B -2B -3B

1.2 Ratios

GTH has a Return On Assets of -82.89%. This is in the lower half of the industry: GTH underperforms 73.64% of its industry peers.
GTH has a Return On Equity of -148.03%. This is in the lower half of the industry: GTH underperforms 65.99% of its industry peers.
Industry RankSector Rank
ROA -82.89%
ROE -148.03%
ROIC N/A
ROA(3y)-90.46%
ROA(5y)-106.52%
ROE(3y)-123.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GTH Yearly ROA, ROE, ROICGTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 50 -50 -100 -150

1.3 Margins

GTH's Gross Margin of 43.25% is fine compared to the rest of the industry. GTH outperforms 79.08% of its industry peers.
GTH's Gross Margin has improved in the last couple of years.
GTH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y10.26%
GTH Yearly Profit, Operating, Gross MarginsGTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

GTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GTH has been increased compared to 1 year ago.
The debt/assets ratio for GTH is higher compared to a year ago.
GTH Yearly Shares OutstandingGTH Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
GTH Yearly Total Debt VS Total AssetsGTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of -8.92, we must say that GTH is in the distress zone and has some risk of bankruptcy.
GTH's Altman-Z score of -8.92 is on the low side compared to the rest of the industry. GTH is outperformed by 75.68% of its industry peers.
GTH has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, GTH is not doing good in the industry: 61.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -8.92
ROIC/WACCN/A
WACC8.31%
GTH Yearly LT Debt VS Equity VS FCFGTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 1B -1B 2B

2.3 Liquidity

A Current Ratio of 1.82 indicates that GTH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.82, GTH is doing worse than 79.59% of the companies in the same industry.
GTH has a Quick Ratio of 1.71. This is a normal value and indicates that GTH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.71, GTH is doing worse than 79.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.71
GTH Yearly Current Assets VS Current LiabilitesGTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

GTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -61.92%.
Looking at the last year, GTH shows a very strong growth in Revenue. The Revenue has grown by 22.31%.
Measured over the past years, GTH shows a very strong growth in Revenue. The Revenue has been growing by 45.15% on average per year.
EPS 1Y (TTM)-61.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-397.82%
Revenue 1Y (TTM)22.31%
Revenue growth 3Y26.24%
Revenue growth 5Y45.15%
Sales Q2Q%342.96%

3.2 Future

Based on estimates for the next years, GTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.08% on average per year.
GTH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.46% yearly.
EPS Next Y20.69%
EPS Next 2Y18.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.16%
Revenue Next 2Y24.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GTH Yearly Revenue VS EstimatesGTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
GTH Yearly EPS VS EstimatesGTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GTH. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GTH Price Earnings VS Forward Price EarningsGTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GTH Per share dataGTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

GTH's earnings are expected to grow with 18.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.08%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GENETRON HOLDINGS LTD-ADR

NASDAQ:GTH (3/28/2024, 8:14:34 PM)

After market: 4.0201 0 (-0.12%)

4.025

+0.01 (+0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-13 2023-11-13
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap127.29M
Analysts80
Price Target1.39 (-65.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 1.79
EV/EBITDA N/A
EPS(TTM)-3.54
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)-2.37
FCFYN/A
OCF(TTM)-2.01
OCFYN/A
SpS2.84
BVpS2.39
TBVpS2.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.89%
ROE -148.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.25%
FCFM N/A
ROA(3y)-90.46%
ROA(5y)-106.52%
ROE(3y)-123.51%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5Y10.26%
F-Score2
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 106.07%
Cap/Sales 12.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.71
Altman-Z -8.92
F-Score2
WACC8.31%
ROIC/WACCN/A
Cap/Depr(3y)112.06%
Cap/Depr(5y)117.32%
Cap/Sales(3y)13.51%
Cap/Sales(5y)13.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-397.82%
EPS Next Y20.69%
EPS Next 2Y18.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.31%
Revenue growth 3Y26.24%
Revenue growth 5Y45.15%
Sales Q2Q%342.96%
Revenue Next Year25.16%
Revenue Next 2Y24.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.19%
OCF growth 3YN/A
OCF growth 5YN/A